07 Jan 2001

Blastoestimulina 2% - España

Updated: 07 Jan 2001

Blastoestimulina 2% polvo 5 g

Cicatrización de: heridas, quemaduras, úlceras tórpidas, úlceras de córnea, lesiones ulcerosas de la lepra etc.

Blastoestimulina 2% Description, Presentation and Dosage

Blastoestimulina 2% Description

Blastoestimulina 2% Drug Class Description

Cicatrizantes

Blastoestimulina 2% Drug Description

POLVO USO TOPICO

Blastoestimulina 2% Presentation

Blastoestimulina 2% Presentation

Ampollas: dosis de ataque: 25 mg. (2,5 ml) vía i.m. o s.c. profunda al día ó 3 veces por semana; dosis de mantenimiento: 25 mg (2,5 ml) por vía i.m. cada 3 ó 4 días. Polvo: 1 a 3 aplicaciones al día. Aerosol: Pulverizar una ligera capa de producto sobre la herida, 1-3 veces al día.

Blastoestimulina 2% Manufacturer

ALMIRALL PRODESFARMA

Related Learning Zones

CLL Knowledge Centre and CME

CLL Knowledge Centre and CME

The Chronic Lymphocytic Leukaemia (CLL) Knowledge Centre contains useful information arranged within four main sections: ‘Disease Awareness’, ‘Events’, ‘Resources’, and 'CME'. Healthcare professionals will find information on pathophysiology, signs and symptoms of CLL, diagnosis, prognosis, treatment and management options, an upcoming events calendar and an external links listing,

The CME activity ‘Treatment Optimisation in Chronic Lymphocytic Leukaemia’ has been EACCME-accredited and awarded 1 CME credit. Test your knowledge by answering quiz questions based on patient case study scenarios.

Type 2 Diabetes Knowledge Centre and CME

Type 2 Diabetes Knowledge Centre and CME

The Type 2 Diabetes Learning Zone comprises the Type 2 Diabetes Mellitus Knowledge Centre containing current epidemiology statistics, current diagnosis criteria from WHO and ADA, treatment options and latest guidelines; a Therapy Focus area compiling material on emerging insulin/incretin treatment combinations; and two free CME activities, which are the EACCME-accredited ‘Role of Newer Therapies for Type 2 Diabetes in Combination with Insulin’ (worth 1 CME credit) and ‘Best Practice in Type 2 Diabetes: Update on Incretin Therapies in Combination with Insulin’. 

Blastoestimulina 2% Dosage

Blastoestimulina 2% Precautions, Reactions and Contraindications

Blastoestimulina 2% Special Precautions

Blastoestimulina 2% Adverse Reactions

Blastoestimulina 2% Adverse Reactions

Descamación de la piel.

Related Drugs - Dermatología

Back to top